SCHEMBL21387799

SCHEMBL21387799

Cc1c(C(N)O)cc(-c2ccccc2)n1Cc1ccc2c(c1)OCO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
TSHR P16473 3/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 4/20 0.48
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
CASP1 P29466 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
EDNRB P24530 4/20 0.46
EDNRA P25101 3/20 0.46
THRB P10828 1/20 0.43
NOX4 Q9NPH5 1/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21565630 0.91 SMN1; SMN2 (0.50) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL21387721 0.89 THRB (0.48) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL20386134 0.80 TSHR (0.55) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL30501034 0.80 TSHR (0.55) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL28331420 0.77 SMN1; SMN2 (0.54) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL28330093 0.75 SMN1; SMN2 (0.48) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL21381476 0.75 SMN1; SMN2 (0.53) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL30501032 0.72 SMN1; SMN2 (0.55) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL20386120 0.72 SMN1; SMN2 (0.55) SMN1; SMN2TSHRLMNAMAPTKDM4E
SCHEMBL20379069 0.70 LMNA (0.53) SMN1; SMN2TSHRLMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP disclosed